Python for Research Scientists

Published on : Published by : BioBuzz Media

Python is a popular scripting language that is used by data professionals because of its many-popular statistical libraries. The live remote three-day lecture and hands-on computer-based laboratory workshop is designed [….]

EV Analytics: Know your Process & Define your Product

Published on : Published by : Chris Frew

Size, heterogeneity, complex composition, and varying manufacturing processes make exosomes or extracellular vesicles a challenge for conventional analytical tools and strategies. Without thorough characterization from start to finish, you’ll be [….]

Kite Launches Program to Attract and Hire Veterans

Published on : Published by : Steven Surdez

Kite’s cell manufacturing facility in Frederick has recently launched what it calls its Veteran Pathways Program. The program is led by veteran hiring program strategist Bre Cameron. Cameron is a Navy veteran with more than a decade of experience in talent acquisition. 

Miltenyi Biotec promotes Markus Weiss to Executive Vice President

Published on : Published by : BioBuzz Media

Markus Weiss, who in this role is responsible for supporting the North American Business Units and Divisions has 18 years of experience in operationalizing strategy, preserving and growing value, scaling culture as well as business transformations. He is experienced in divisional, regional and country level leadership roles in technology, life science, manufacturing, construction and financial services.

5 Top Maryland Cell and Gene Therapy Companies Actively Searching for Talent

Two businesspeople shaking hands, with logos of Kite Pharma, NextCure, Arcellx, NexImmune, and MaxCyte
Published on : Published by : Steven Surdez

The BHCR cluster, in particular, includes a host of emerging and established cell and gene therapy companies, as well one of the deepest and most advanced biomanufacturing infrastructures in the U.S. While the cell and gene therapy industry still faces challenges like high manufacturing costs, high cost per dose to patients and complex supply chain issues, this sector remains very healthy and is continuing to grow rapidly in our region and globally.

CRB Life Sciences Report Highlights Looming Changes in Cell Therapy Space

Pink and purple DNA strands with "Horizons" text
Published on : Published by : Alex Keown

The Horizon report is based on survey responses from more than 500 industry leaders who provide insight into all corners of the industry. The investigation of cell and gene therapies is proving to be a disruptive space that is reshaping biopharma business models. When cell therapies first went into human testing, Walters said the big question on the minds of the scientists was, “will it work?”

Cartesian Therapeutics to double footprint, headcount in Gaithersburg

Published on : Published by : Chris Frew

Gaithersburg’s Cartesian Therapeutics Inc. is expanding its local footprint and initiating an aggressive hiring spree as the company bolsters its leadership team — and looks to get a cell therapy candidate through the clinic.
The biopharma, which already occupies about 4,500 square feet at 704 Quince Orchard Road, is taking over another 3,500 square feet adjacent to its existing space in the building, Dr. Murat Kalayoglu, president and CEO of Cartesian, told the Washington Business Journal.
The company declined to disclose the projected cost of the expansion, citing confidentiality reasons per its contract with Alexandria Real Estate Equities Inc. (NYSE: ARE), which in partnership with South Duvall — an affiliate of Rockville’s Scheer Partners — paid $6.9 million for the 80,000-square-foot office building in 2018. The building in the Gaithersburg biotech corridor is also home to a flurry of local players, including Novavax Inc. (NASDAQ: NVAX), miRecule Inc., VLP Therapeutics Inc. and others.